Promethera Biosciences retweeted
Si vous avez loupé le 15H Biotech express du jour ! biotech-finances.com/15h-bio…
Promethera Biosciences retweeted
Promethera s'allie à un partenaire japonais - L'Echo lecho.be/entreprises/pharma-… #biotech
Promethera Biosciences retweeted
Also known as the silent killer, late-stage #NASH can only be treated with a liver transplant. Imagine a single liver that could save not only one life but thousands! Find out what @Promethera is doing to save lives 👉bit.ly/2oJdWos
Promethera Biosciences retweeted
How is the current landscape of #NASH therapies evolving? Could a #celltherapy be the solution to this liver disease? Check out what @Promethera is doing to help 👉 bit.ly/2oJdWos
Promethera Biosciences retweeted
Your liver will take excess sugar and turn it into liver fat — you don't want this
The effects of sugar on your brain and body
Too much sugar has much more negative side effects than just weight issues. Sugar is the signal driver for a whole suite of diseases that will hit you later on in life.
Promethera Biosciences retweeted

L'Echo@lecho9 May 2019
🇧🇪!
BelgiumConnected via WebLocation may be affected by a proxy or VPN.Account-level information, not a live location or per-post device.
Promethera lance son étude clinique contre la maladie du foie gras bit.ly/2Ly0tux
Promethera Biosciences retweeted
Cell therapy weekly: Shanghai unveils new cell therapy park, @bcmhouston uncovers mechanism which prevents retinal regeneration and first patient dosed in @Promethera phase IIa steatohepatitis trial. bit.ly/2H8zZv6
Promethera Biosciences retweeted
Sugar consumption has increased 5x over the last century, and mounting evidence ties it directly to NASH and a host of other diseases.
Why? Because Fructose is a poison to the liver, and long term exposure is no different than alcohol.
nashaware.com/2019/02/15/our…
Promethera Biosciences retweeted
"@Promethera has raised a Series D round of €39.7M $44.4M, which will fund the development of the first #CellTherapy for liver failure and #NASH." 💰🙌🏻labiotech.eu/medical/prometh…
Promethera Biosciences retweeted

L'Echo@lecho7 May 2019
🇧🇪!
BelgiumConnected via WebLocation may be affected by a proxy or VPN.Account-level information, not a live location or per-post device.
Promethera Biosciences retweeted
.@Promethera's Chief Scientific & Medical Officer @ESokal on the company's #HepaStem platform & potential to treat acute & chronic #liverdisease at #Med19 - in room Gaudi 2 and online: bit.ly/2vi0eIR
Promethera Biosciences retweeted
#Celltherapy weekly: #stemcells show promise for acute-on-chronic #liverfailure, collaboration will develop #iPSC-based #diabetes therapies, and gene found to link regeneration in brain and gut. @Promethera @RutgersU bit.ly/2Pfmgp1
Promethera Biosciences retweeted
Promethera's First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials buff.ly/2Xdgeb1
Promethera Biosciences retweeted

L'Echo@lecho15 Apr 2019
🇧🇪!
BelgiumConnected via WebLocation may be affected by a proxy or VPN.Account-level information, not a live location or per-post device.
Promethera Biosciences retweeted
Kick-off of #BioEuropeSpring ! Meet BioWin and its members @Eurogentec, @itech_incubator, Imcyse, ASIT-biotech, Aseptic Technologies, @keyrus_be, iTeos Therapeutics, @BCI_Pharma, @BiologicsforAll, CER Groupe, @4Clinics , @Promethera, @VitriCell & NOVADIP Biosciences booth #24!
Promethera Biosciences retweeted
Le premier 15H Biotech express de l'année est paru !
biotech-finances.com/15h-bio…
Promethera Biosciences retweeted
Promethera Biosciences (@Promethera) have received a leg-up for the Asian market in the form of a €10m investment from Japanese conglomerate ITOCHU bit.ly/2s5PAn2
Promethera Biosciences retweeted
Belgium-based clinical-stage pharmaceutical company Promethera Biosciences SA has held the first close of its Series D funding at 10 million euros ($11.4 million). @Promethera investsize.com/en/belgium%E2…















